Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyene phosphatidylcholine injection for drug-induced liver injury (full vs conventional dose)
ChiCTR2400086918Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of polyene phosphatidylcholine in Drug-induced hepatitis (DILI) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: ALT. Started Jul 2024; status: recruiting.
02
Drugs
polyene phosphatidylcholine
03
Conditions
Drug-induced hepatitis (DILI)
Beyond the preview
Go deeper on ChiCTR2400086918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086918.